Session » Rheumatoid Arthritis - Clinical Aspects Poster II

Date: Monday, November 9, 2015

Time: 9:00AM-11:00AM

Meeting: 2015 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 1591

A Low Adiponectin Level in Rheumatoid Arthritis Is Associated with Coronary Artery Disease

9:00AM-11:00AM: Abstract Number: 1503

A Systematic Screening of Comorbidities By the Rheumatologist in Inflammatory Rheumatisms Impacts Chronic Disease Care

9:00AM-11:00AM: Abstract Number: 1580

Abnormal High Density Lipoproteins in Synovial Fluid from Patients with Rheumatoid Arthritis Compared to Patients with Non-Inflammatory Arthritis

9:00AM-11:00AM: Abstract Number: 1515

Accounting for Rheumatoid Arthritis in the Determination of 10 Year Cardiovascular Risk

9:00AM-11:00AM: Abstract Number: 1533

Age Related Disability in Daily Life Should be Considered in Older Than Sixty-Five-Year-Old Rheumatoid Arthritis Patient

9:00AM-11:00AM: Abstract Number: 1542

Arterial Vascular Events in Hispanics from Puerto Rico with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1579

Association of Myocardial Abnormalities with N-Terminal Pro-Brain Natriuretic Peptide and Disease Activity in Rheumatoid Arthritis without Cardiac Symptoms, Assessed By Cardiac Magnetic Resonance Imaging

9:00AM-11:00AM: Abstract Number: 1574

Associations of Serum Anti-Malondialdehyde-Acetaldehyde (MAA) Antibodies with Cardiovascular and Respiratory Mortality in Men with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1602

Beta Cells Function and Insulin Resistance during Tocilizumab Treatment in Non-Diabetic RA Patients: Results from a Single-Center Study

9:00AM-11:00AM: Abstract Number: 1581

Cardiac Involvement in Patients with Amyloid a Amyloidosis Due to Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1568

Cardiac Morphology and Function in Patients with Acute Coronary Syndrome Complicated with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1604

Cardiovascular Disease in a Large Incident Cohort of Early Inflammatory Arthritis

9:00AM-11:00AM: Abstract Number: 1540

Cardiovascular Risk Management in Rheumatoid Arthritis Patients

9:00AM-11:00AM: Abstract Number: 1505

Carotid Artery Atherosclerosis in Patients with Active Rheumatoid Arthritis: Predictors of Plaque Occurrence and Progression over 24 Weeks

9:00AM-11:00AM: Abstract Number: 1538

Clinical Analysis of 30 Rheumatoid Arthritis Patients Complicated with Malignant Lymphoma, Especially Methotrexate-Related Lymphoproliferative Disorder

9:00AM-11:00AM: Abstract Number: 1559

Clinical Characteristics and Medication Use Among Arab Patients with Rheumatoid Arthritis in Some Arab States

9:00AM-11:00AM: Abstract Number: 1599

Clinical Characteristics of Interstitial Lung Disease (ILD) in Rheumatoid Arthritis (RA) Patients in High Resolutional CT (HRCT) and Titer of Anti Citrullinated Peptide Antibodies (anti-CCP2)

9:00AM-11:00AM: Abstract Number: 1562

Clinical Correlates, Outcomes and Predictors of Episcleritis and Scleritis Associated with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1548

Comparison of 5 Cardiovascular Risk Calculators in a Hispanic Rheumatoid Arthritis Cohort

9:00AM-11:00AM: Abstract Number: 1545

Comparison of Statin Eligibility According to the Adult Treatment Panel III, ACC/AHA Blood Cholesterol Guideline and Presence of Carotid Plaque By Ultrasound in Hispanics with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1539

Control of Modifiable Cardiovascular Risk Factors in Rheumatoid Arthritis Patients Compared to Traditional High-Risk Cardiovascular Disease Patients

9:00AM-11:00AM: Abstract Number: 1522

Correlation of Oxidized Low Density Lipoprotein Levels with Carotid Intima Media Thickness in Rheumatoid Arthritis Patients

9:00AM-11:00AM: Abstract Number: 1587

Deriving a Comorbidity Index Form the Meddra Classification: Performance of Rheumatic Disease Comorbidity Index, Charlson-Deyo Index and Functional Comorbidity Index Among Patients with RA in NOR-DMARD Cohort

9:00AM-11:00AM: Abstract Number: 1525

Detection of Previous Tuberculosis Infections in Japanese Rheumatoid Arthritis Patients: Comparison of Two Interferon-G Releasing Assays and the Impact of CD4-Positive Lymphocytes

9:00AM-11:00AM: Abstract Number: 1596

Diagnosis of Carotid Plaque By 4 Cardiovascular Risk Scores in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1563

Dyslipidemia and Hyperglycemia, Two Cardiometabolic Parameters, Independently Predict Poor Outcome in Early Rheumatoid Arthritis: Results from Espoir Cohort

9:00AM-11:00AM: Abstract Number: 1576

Effect of Conventional Synthetic and Biological Disease Modifying Anti-Rheumatic Drugs on the Immunogenicity of Hepatitis B Vaccine in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1553

Effect of Drug Therapy on Net Cholesterol Efflux Capacity of HDL-Enriched Serum in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1537

Effect of TNF-Alpha Blockade on Body Composition in Inflammatory Rheumatic Disease: Systematic Review with Meta-Analysis

9:00AM-11:00AM: Abstract Number: 1526

Employment and Quality of Life Among Patients with Rheumatoid Arhtritis in Four Latin-American Countries

9:00AM-11:00AM: Abstract Number: 1570

End Stage Renal Disease (ESRD) in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1506

EULAR Recommendations for Cardiovascular Risk Management in Patients with Rheumatoid Arthritis and Other Inflammatory Joint Diseases – 2015 Update

9:00AM-11:00AM: Abstract Number: 1524

Evaluation of Changes in Cardiovascular Risk Factors Among Patients with RA Prescribed Biologic Dmards

9:00AM-11:00AM: Abstract Number: 1601

Evaluation of Glucose Metabolism in Rheumatic Patients: A Case Control Study

9:00AM-11:00AM: Abstract Number: 1550

Flares of Disease Activity As Risk Factor for the Occurrence of Myocardial Infarction in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1555

Geography and the Influence of Comorbidity on the Prevalence of Depression in Patients with Rheumatoid Arthritis,a Study Across Seventeen Countries

9:00AM-11:00AM: Abstract Number: 1565

High Disease Activity over Time and Persistent Inflammation Are Associated with Increased Risk of Cardiovascular Disease in Patients with Early Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1571

How Substantive Is Heart Rate Variability As a Predictor of Anti-TNF Treatment Outcome for Inflammatory Arthritis?

9:00AM-11:00AM: Abstract Number: 1583

Identifying Risk Factors for Progression of Rheumatoid Arthritis-Associated Interstitial Lung Disease

9:00AM-11:00AM: Abstract Number: 1552

Illness Perceptions in Rheumatoid Arthritis: A Comparison of Canadian and Nigerian Patients

9:00AM-11:00AM: Abstract Number: 1500

Impact of Menopause on Functional Impairment of Rheumatoid Arthritis Patients

9:00AM-11:00AM: Abstract Number: 1589

Impact of Osteoarthritis of the Hand on Disease Activity Scores and Health Status in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1595

Impaired Coronary Flow Reserve in Rheumatoid Arthritis: A Robust Indicator of Cardiac Structure Associated with Systemic Inflammation and Rheumatoid Arthritis Treatments

9:00AM-11:00AM: Abstract Number: 1547

Implementing an Electronic Medical Recorded-Based Clinical Decision Support Tool Did Not Improve Cardiovascular Risk Screening in Rheumatoid Arthritis Patients

9:00AM-11:00AM: Abstract Number: 1514

Incidence and Risk Factors of Malignancy in a Cohort of Rheumatoid Arthritis Patients from Singapore

9:00AM-11:00AM: Abstract Number: 1512

Incidence of Co-Morbid Autoimmune Diseases in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1588

Increased Fracture Risk in Patients with Early Rheumatoid Arthritis: A Prospective General Population-Matched Cohort Study

9:00AM-11:00AM: Abstract Number: 1511

Increased Prevalence of Anti-Nuclear and Anti-SSA Autoantibodies in African American Rheumatoid Arthritis Patients Versus Matched Caucasian Rheumatoid Arthritis Patients

9:00AM-11:00AM: Abstract Number: 1504

Increased Risk of Thromboembolism Among Patients with VTE Association with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1502

Initiating Statin Medication and Risk of Fatigue in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1564

Initiation of Disease Modifying Therapies and Subsequent Weight Change in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1523

Ischemia Modified Albumin Levels in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1582

Joint Damage Associated with Loss of Body Mass in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1508

Lipid Target Achievement Among Patients with Recent-Onset Rheumatoid Arthritis during the First Six Years of Follow-up: Results from a French Multicenter Cohort of Early Arthritis

9:00AM-11:00AM: Abstract Number: 1584

Metabolic Syndrome Is Associated with Disease Activity in Patients with Rheumatoid Arthritis: A Prospective Cohort Study

9:00AM-11:00AM: Abstract Number: 1530

Neutrophil Function and Survival Unaffected in Healthy Subjects Following Single Administration of Tocilizumab

9:00AM-11:00AM: Abstract Number: 1594

No Association of Anti-Citrullinated Peptide Antibodies with Coronary Artery Calcification in Two Rheumatoid Arthritis Cohorts without Clinical Cardiovascular Disease

9:00AM-11:00AM: Abstract Number: 1598

Obesity and the Risk for Development of Rheumatoid Arthritis – Results from a Population-Based Nested Case-Control Study

9:00AM-11:00AM: Abstract Number: 1567

Occurrence of Serious Infection in Patients with Rheumatoid Arthritis Treated with Biologics and Denosumab Observed in a Clinical Setting

9:00AM-11:00AM: Abstract Number: 1532

Occurrence of Valvular Heart Disease in Rheumatoid Arthritis: A Population Based Study

9:00AM-11:00AM: Abstract Number: 1577

Periodontal Evaluation Is Associated with Increased Likelihood of Achieving Low Disease Activity in Rheumatoid Arthritis with Methotrexate

9:00AM-11:00AM: Abstract Number: 1572

Plasma Apolipoprotein B48 Levels in Patients with Rheumatoid Arthritis: Evaluating Novel Cardiovascular Risk Factors

9:00AM-11:00AM: Abstract Number: 1573

Plasma Pentraxin 3 Concentration Is Associated with Progression of Radiographic Joint Damage but Not with Carotid Atherosclerosis in Female Patients with Rheumatoid Arthritis: Results from a 3-Year Prospective Study

9:00AM-11:00AM: Abstract Number: 1519

Pleuropulmonary Manifestations in Rheumatoid Arthritis Patients

9:00AM-11:00AM: Abstract Number: 1528

Predictors of Employment, Work Productivity Loss, Activity Impairment, and Regaining Employment in Latinos with Rheumatoid Arthritis in the United States

9:00AM-11:00AM: Abstract Number: 1549

Prevalence of Co-Morbidities and Evaluation of Their Monitoring in Korean Patients with RA: Comparison with the Results of an International, Cross-Sectional Study (COMORA)

9:00AM-11:00AM: Abstract Number: 1501

Prevalence of Unassessed and Uncontrolled Cardiovascular Disease Risk Factors Among Rheumatoid Arthritis Patients in an Academic Rheumatology Practice

9:00AM-11:00AM: Abstract Number: 1600

Pulmonary Manifestations in Early Rheumatoid Arthritis: A 6 Month Follow up Study

9:00AM-11:00AM: Abstract Number: 1516

Quality Improvement in Elderly Patients with Rheumatoid Arthritis: Pharmacotherapy and Identification of Cognitive Dysfunction

9:00AM-11:00AM: Abstract Number: 1513

Reactivation of Hepatitis B-Infection in German Patients with Inflammatory Rheumatic Diseases Treated with Biologics – a Monocentric Analysis Involving 1107 Patients

9:00AM-11:00AM: Abstract Number: 1518

Relationship Between Estimated Sodium and Potassium Intake with Blood Pressure and Inflammatory Markers in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1544

Resiliency As a Predictor of Depressive Symptoms in Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1590

Rheumatoid Arthritis-Related Interstitial Lung Disease (RA-ILD): Methotrexate and the Extension of Lung Disease Are Associated to Prognosis

9:00AM-11:00AM: Abstract Number: 1551

Rheumatoid Vasculitis: A Decline in the XXI Century

9:00AM-11:00AM: Abstract Number: 1507

Risk of Obstructive Sleep Apnea in Rheumatoid Arthritis Patients: The Frequency and Associated Disease Features

9:00AM-11:00AM: Abstract Number: 1569

Rituximab Efficacy in the Treatment of Diffuse Interstitial Lung Disease Associated with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1603

Safety of Biologic and Non-Biologic Disease-Modifying Antirheumatic Drug (DMARD) Therapy in Veterans with Rheumatoid Arthritis and Chronic Hepatitis C Infection

9:00AM-11:00AM: Abstract Number: 1520

Safety, Clinical and Immunologic Effectiveness of the Live Zoster Vaccine Administered to Patients Receiving Anti-TNF Biologics

9:00AM-11:00AM: Abstract Number: 1521

Screening for Urinary Tract Infection in Rheumatoid Arthritis Patients Treated with TNF-Inhibitors in the Daily Clinic

9:00AM-11:00AM: Abstract Number: 1536

Sensorineural Hearing Impairment and Subclinical Atherosclerosis in Rheumatoid Arthritis Patients without Traditional Cardiovascular Risk Factors

9:00AM-11:00AM: Abstract Number: 1558

Serum Cathepsin S and Cystatin C Relation with Carotid Subclinical Atheromatosis in Rheumatoid Arthritis Patients

9:00AM-11:00AM: Abstract Number: 1527

Serum Inflammation Identifies Increased Risk of Frailty in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1509

Serum Nitrite Levels in Rheumatoid Arthritis and Relationship to Cardiovascular Risk Factors and Atherosclerosis Biomarkers

9:00AM-11:00AM: Abstract Number: 1578

Serum Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibody Are Associated with Subclinical Interstitial Lung Disease in the Multi-Ethnic Study of Atherosclerosis: A Population-Based Study

9:00AM-11:00AM: Abstract Number: 1575

Serum Vascular Cell Adhesion Molecule-1 (VCAM-1) Levels Are Associated with Vascular Dysfunction and Increased Cardiovascular Risk in an Animal Model and Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1554

Severe Pneumonia after a 13-Prevalent Pneumonoccal Conjugate Vaccine (Prevena 13) Among Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1592

Sex Differences in Cardiovascular Risk Factors and Event Rates in Patients with Rheumatoid Arthritis – Data from 13 Rheumatology Centers

9:00AM-11:00AM: Abstract Number: 1541

Subgroups of Established Rheumatoid Arthritis Patients Can be Characterized By Patient and Physician Assessment Discrepancy, Anxiety and Depression and Presence of Depression Might be Associated with Slower Response to Treatment

9:00AM-11:00AM: Abstract Number: 1593

Telomere Length and Cardiovascular Risk in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1534

Temporal Trends and Outcomes of Acute Myocardial Infarction in Rheumatoid Arthritis Hospitalizations

9:00AM-11:00AM: Abstract Number: 1510

The Association Between HDL Cholesterol Efflux Capacity, Citrullinated ApoA1 and Anti-Citrullinated ApoA1 Antibodies in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1531

The Changing Face of Septic Arthritis Complicating Rheumatoid Arthritis in the Era of Biotherapies. Retrospective Single-Center Study over 35 Years

9:00AM-11:00AM: Abstract Number: 1535

The Clinical Impact of Overweight in Rheumatoid Arthritis Patients: Comparison Between Korean and Other Countries within the Comora Study

9:00AM-11:00AM: Abstract Number: 1560

The Effect of Anti Estrogen Therapy (AET) on Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1561

The Effect of TNF Blockers on Bone Mineral Density in Rheumatoid Arthritis Patients Receiving Bisphosphonate

9:00AM-11:00AM: Abstract Number: 1557

The Impact of Hindfoot Deformity on Disability of Korean Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1566

The Impact of Severe Extra-Articular Manifestations and Patient Reported Outcome Measures on Cardiovascular Disease in Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1556

The Medication Information-Seeking Behaviors of Rheumatoid Arthritis Patients Who Are Prescribed a New DMARD

9:00AM-11:00AM: Abstract Number: 1529

Trabecular Bone Score in Early Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1543

Traditional Risk Score Underestimates the Cardiovascular Risk in Rheumatoid Arthritis Patients

9:00AM-11:00AM: Abstract Number: 1585

Vaccination Uptake in Patients with Rheumatoid Arthritis Treated with Disease-Modifying Anti-Rheumatic Drug Therapy: A Retrospective Cohort Study Using UK Primary Care Electronic Medical Records

9:00AM-11:00AM: Abstract Number: 1597

Variability in Health Assessment Questionnaire Based on Type of Health Insurance Coverage and Rheumatology Practice

9:00AM-11:00AM: Abstract Number: 1586

Weight Loss in Obese Rheumatoid Arthritis (RA) Patients Improves Disease Activity without Modifying RA Treatment

9:00AM-11:00AM: Abstract Number: 1546

What Is the Impact of Smoking on the Risk of Rheumatoid Arthritis Progression: A Systematic Review of the Risk Factor Paradox

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].